<DOC>
	<DOCNO>NCT00474526</DOCNO>
	<brief_summary>This study evaluate safety immune response Novartis Meningococcal ACWY conjugate vaccine administer routine infant vaccination healthy infant .</brief_summary>
	<brief_title>A Study Evaluate Safety Immune Response Novartis Meningococcal ACWY Vaccine In Infants</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy term 2monthold infant parent/legal representative give write informed consent . Subjects previous suspected disease cause Neisseria meningitidis , Corynebacterium diphtheriae , Clostridium tetani , Poliovirus , Hepatitis B , Haemophilus influenzae type b ( Hib ) , Pneumococcus Bordetella pertussis ; previous immunization meningococcal vaccine vaccine contain meningococcal antigen ( ) prior vaccination Diptheria , Tetanus , Pertussis ( acellular whole cell ) , inactivate polio vaccineIPV oral polio vaccineOPV , H. influenzae type b ( Hib ) Pneumococcus ; household contact and/or intimate exposure individual laboratory confirm N. meningitidis ( serogroups A , C , W135 , Y ) , B. pertussis , Hib , C. diphtheriae , Polio , pneumococcal infection time since birth ; Any serious acute , chronic progressive disease</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>2 Months</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Meningococcal</keyword>
	<keyword>meningitis</keyword>
	<keyword>vaccine</keyword>
	<keyword>infant</keyword>
	<keyword>Meningococcal meningitis</keyword>
	<keyword>Meningococcal disease</keyword>
</DOC>